Product Name: Vildagliptin
CAS No.: 274901-16-5
Appearance: White crystalline powder
Packing: 20 or 25kg fibre drum
Uses: Vildagliptin is the 1st DPP-4 inhibitor to treat patients with type 2 diabets melitus. Currently it is mainly used in oral tablets with dose 50mg, 100mg, and also combined with Metformin HCl (50 mg/500 mg, 50 mg/850 mg and 50 mg/1000 mg).
Product Manager: Allen Li(Dept.6)Email


Vildagliptin was approved by US FDA in Feb 2007 and firstly launched by Novartis, to treat the patients with type 2 diabets Melitus. As an oral anti-diabetic drug of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.

Our Vildagliptin is manufactured in GMP plant, with US FDA/ EU authorities approved. The product is with excellent quality, completed documents. We have big production capacity and mature process to ensure our product with excellent quality and the most competitive price

We appreciate that you contact our product manager directly. You could find the email address above.